| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |